ASH 2013: Dr. Jennifer Brown Discusses the New Data on Obinutuzumab (GA-101 or Gazyva)

[bkoffman]

In my interview with Dr. Brown from ASH 2013 she gives a nice summary and not only how better Obinutuzumab is than Rituximab, but also why to is better, and what this might mean down the line. See: bkoffman.blogspot.com for the video interview.

[jangreen]

Hi great news for us CLLer's. Thanks for the videos

[Mikey47]

Many thanks Brian.